Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a website teach patients to tame gut pain and skip needless hospital tests?

NCT ID NCT06002516

Disease control Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Upper abdominal pain often comes from functional dyspepsia, irritable bowel syndrome, or uncomplicated gallstones. These conditions overlap and many patients do not know that tests and surgery may not help. Researchers are testing a personalized web-based education tool that explains symptoms, red flags, and lifestyle changes, with optional visits to a lifestyle clinic. The trial compares this approach with usual care to see whether it reduces hospital visits and procedures and improves quality of life for adults referred to gastroenterology or surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a personalized web-based education and self-management tool with optional lifestyle clinic visits
What this could lead to
If it works, this approach could give people with common gut and gallbladder pain a way to manage symptoms at home and avoid unnecessary hospital tests.
What could go wrong
This is a single-country study of a web tool, so results may not apply elsewhere. Some people may not engage with online education, and the tool cannot replace a doctor for serious causes of pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 471 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients between 18 and 70 years old. * First referral due to upper abdominal pain (UAP) and symptoms due to Functional dyspepsia (ICPC code 87.02), Irritable Bowel syndrome (ICPC 93.0) or uncomplicated symptomatic cholecystolithiasis (ICPC 98.03). * Proficient in reading and understanding of the Dutch language. * Referred to the outpatient clinic of gastroenterology or surgery. * Providing informed consent. Exclusion Criteria: * Unexplained weight loss * Persistent vomiting * Gastrointestinal bleeding * Any other direct or indirect signs of cancer or upper GI tract bleeding * Anemia * Jaundice * Pregnancy * An expected life span of less than 12 months * Known liver diseases * A history of complicated cholecystolithiasis * A history of inflammatory bowel disease * A history of malignancy, except squamous cell carcinoma (SCC)/basal cell -carcinoma (BCC) * First or second degree relative with history of upper GI malignancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abdominal Pain cholecystolithiasis Colic dyspepsia gallstones irritable bowel syndrome Patient Acceptance of Health Care

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal pain Decision aid Dyspepsia Gallstone; colic Health care utilization Irritable bowel syndrome Patient reported outcomes Upper abdominal pain

Contacts and locations

Locations

  • Radboud University Medical Center

    Nijmegen, Gelderland, 6525 GA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.